miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa

Alix Garcia1, Sylvie Dunoyer-Geindre1, Séverine Nolli1

  • 1Geneva Platelet Group, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Abstract

Insights

MicroRNA-204-5p enhances platelet reactivity by downregulating CDC42 and affecting fibrinogen receptor expression. This finding clarifies the functional role of miR-204-5p in cardiovascular health.

Area of Science:

  • Molecular Biology
  • Hematology
  • Cardiovascular Research

Background:

  • Platelet microRNAs influence cardiovascular patient outcomes.
  • Previous studies linked miR-204-5p to platelet reactivity (PR) in stable cardiovascular patients.
  • Functional mechanisms of miR-204-5p in PR remain unclear.

Purpose of the Study:

  • Validate miR-204-5p as a PR regulator.
  • Investigate mechanistic pathways in human megakaryocyte-derived platelet-like structures (PLS).

Main Methods:

  • Differentiated human hematopoietic stem cells into megakaryocytes.
  • Transfected megakaryocytes with miR-204-5p and analyzed PLS.
  • Assessed PR using flow cytometry, GPIIbIIIa activation, and fibrinogen binding assays.
  • Evaluated miR-204-5p's impact on CDC42 via qPCR and Western blot.

Main Results:

  • miR-204-5p transfection altered megakaryocyte cytoskeleton and PLS morphology.
  • PLS from miR-204-5p-transfected cells exhibited enhanced reactivity.
  • This phenotype was linked to GPIIbIIIa regulation and CDC42 downregulation.
  • CDC42 silencing mimicked the effect of miR-204-5p.

Conclusions:

  • Functionally validated miR-204-5p as a regulator of platelet reactivity.
  • Demonstrated that miR-204-5p exerts its effect via CDC42 downregulation.
  • Established a link between miR-204-5p, CDC42, and fibrinogen receptor expression in PR.

Related Concept Videos

IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
13.2K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.3K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.0K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.3K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
9.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
808